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Sustained agonist-induced production of the second
messengers InsP3 and diacylglycerol requires steady
delivery of phosphatidylinositol (PtdIns) from its site
of synthesis in the ER to the plasma membrane
(PM) tomaintain PtdIns(4,5)P2 levels. Similarly, phos-
phatidic acid (PtdOH), generated from diacylglycerol
in the PM, has to reach the ER for PtdIns resynthesis.
Here, we show that the Drosophila RdgB homolog,
Nir2, a presumed PtdIns transfer protein, not only
transfers PtdIns from the ER to the PMbut also trans-
fers PtdOH to the opposite direction at ER-PM con-
tact sites. PtdOH delivery to the ER is impaired in
Nir2-depleted cells, leading to limited PtdIns synthe-
sis and ultimately to loss of signaling from phospho-
lipase C-coupled receptors. These studies reveal a
unique feature of Nir2, namely its ability to serve as
a highly localized lipid exchanger that ensures that
PtdIns synthesis is matched with PtdIns(4,5)P2
utilization so that cells maintain their signaling
competence.
INTRODUCTION
Non-vesicular lipid transfer between the membranes of different
organelles has been increasingly recognized as a means by
which cells maintain distinct lipid compositions of their different
membranes in the face of intense vesicular membrane trafficking
(Lev, 2012; Prinz, 2010). Such mechanisms have been recently
identified for cholesterol transport between the ER and the Golgi
both in yeast (de Saint-Jean et al., 2011) and mammalian cells
(Mesmin et al., 2013) or for the transport of ceramide and gluco-
syl ceramide between the same two membrane compartments
(D’Angelo et al., 2007; Hanada et al., 2003). Moreover, other lipid
transfer proteins, such as Sec14 or its five homologs in yeast
(Sfh1–5), have also been found to play important roles in lipid ho-
meostasis in yeast (Bankaitis et al., 2010). Importantly, in almost
all cases, phosphoinositides have been implicated in the control
of these non-vesicular lipid transfer processes (Kim et al.,
2013b).DeveIronically, one of the long-outstanding and unresolved ques-
tions in lipid signaling is related to the process by which phos-
phatidylinositol (PtdIns) gets to the plasma membrane (PM)
from its site of synthesis in the ER. PtdIns in the PM is the ultimate
precursor of PtdIns(4,5)P2, a critically important phosphoinosi-
tide that controls a multitude of processes in the PM (Balla,
2013). Consumption of PtdIns(4,5)P2 occurs when phospholi-
pase C (PLC) is activated by cell-surface receptors to generate
inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and diacylglycerol
(DG), the two important messengers linked to a variety of cellular
responses (Berridge, 1984). Without replenishment of the limited
PM PtdIns(4,5)P2 pool from newly synthesized PtdIns, cells are
unable to maintain their transmembrane signaling. Early studies
of the 1950s and 1960s (Hokin and Hokin, 1955, 1964) have
postulated that the products of PLC activation (at that time, it
was believed that PLC acts directly on PtdIns) get recycled.
DG is phosphorylated to phosphatidic acid (PtdOH), which is
then converted back to PtdIns via two enzymatic steps, with
CDP-DGbeing an intermediate (Agranoff et al., 1958) (Figure 1A).
For this ‘‘cycle’’ to work efficiently, PtdIns has to be transferred
from the ER to the PM and PtdOH has to be transferred from
the PM to the ER. PtdIns transfer proteins (PITPs) have long
been identified (Cockcroft and Garner, 2011; Ile et al., 2006),
but it is still not clear which, if any, are important for PtdIns trans-
fer between the ER and the PM. In contrast, PtdOH transfer pro-
teins between the PM and the ER have not yet been described,
neither is it understood how PtdIns and PtdOH transfer is coor-
dinated between these two membranes.
During studies of these questions, we observed that the Nir2
protein was important for CDP-DG and PtdIns synthesis during
agonist stimulation. Nir2 and Nir3 (also called PITPnm1 and
PITPnm2) are mammalian homologs of the Drosophila RdgB
protein possessing PITP domains at their N termini (Trivedi and
Padinjat, 2007). RdgBmutant flies undergo retinal degeneration,
presumably because of a defect in the maintenance of
PtdIns(4,5)P2 in their photoreceptor membranes (Milligan et al.,
1997). According to current views, RdgB transfers PtdIns from
the ER to the PM (Trivedi and Padinjat, 2007). Recent studies
suggested that Nir2 supports the maintenance of PtdIns(4,5)P2
pools via its PtdIns transfer function at ER-PM contact sites
(Chang et al., 2013; Kim et al., 2013a). Here, we report that
Nir2 is an intricate lipid transfer device that transports PtdOH
from the PM to the ER, by a process that is tightly coupled to
PtdIns(4,5)P2 hydrolysis and PtdIns transport in the otherlopmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Inc. 549
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Figure 1. Nir2 Depletion Affects Phosphoinositide Cycle Intermediates
(A) Current models of the phosphoinositide cycle and its compartmental distribution.
(B) Labeling HEK293-AT1 cells withmyo-[3H]inositol (24 hr) after 3-day knockdown of the indicated PITPs (see Figure S1A for analysis of knockdown efficiency).
Lipids were extracted and separated by TLC and quantified by densitometry of exposed films from TLC plates treated with Enhancer. Grand means ± SEM of
three experiments are shown, each performed in duplicate.
(C) After 3-day knockdown with control or Nir2 siRNAs, cells were labeled with 32P-phosphate for 1 hr followed by a 10-min treatment with AngII (107 M) or
solvent. Lipids were extracted and separated by TLC, then subjected to phosphorimage analysis. Grand means ± SEM of five experiments are shown, each
performed in duplicate.
(D) Calculated PtdOH/PtdIns activity ratios normalized to absolute controls (grand means ± SEM, n = 5; **p < 0.05, ***p < 0.001, using two-way ANOVA).
(E) Incorporation of [3H]cytidine into CDP-DG in HEK293-AT1 cells. Cell were treated with the indicated siRNAs for 3 days and inositol depleted for the last 16 hr.
Cells were then stimulatedwith AngII (107M) for 1 hr in the presence of the isotopewith or without pretreatment with 10mMLi+ for 30min prior to stimulation. Top
panel shows representative TLC, and the graph below shows quantification (means ± range) from two independent experiments. This result was reproduced in
ten other experiments in the course of these studies. For rescue experiments, see Figure S1C.
(F) Effect of Nir2 knockdown onmyo-[3H]inositol incorporation into phosphoinositides during a short labeling (2 hr) in the presence or absence of AngII (2 hr) (see
Figure S1B for myo-[3H]inositol incorporation kinetics).direction. Nir2 is recruited to ER-PM junctions during PLC activa-
tion and is critically important for the utilization of PtdOH gener-
ated in the PM for PtdIns synthesis in the ER. Nir2 is, therefore, a
critical component of the PI cycle that, via its lipid exchange
function, coordinates PtdIns synthesis and transfer with
PtdIns(4,5)P2 utilization to ensure maintenance of this important
signaling lipid in the PM.
RESULTS
Nir2 Is Important for Both PtdIns and PtdOHMetabolism
To identify the transfer protein(s) responsible for PtdIns transfer
between the ER and the PM, we performed RNAi experiments550 Developmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Intargeting the known mammalian PITP proteins. We measured
[3H]-inositol incorporation into phosphoinositides in intact cells
with the idea that inhibition of PtdIns transfer between the ER
and PM would impede the flux of 3H from PtdIns made in the
ER to PtdIns(4,5)P2 that is synthesized in the PM (Figure 1A).
The expectation was that 3H-inositol labeling of PtdIns(4,5)P2
would be selectively impaired when the relevant PITP was elim-
inated. Inactivation of either or both class I PITPs by RNAi-medi-
ated gene silencing in HEK293 cells stably expressing the AT1a
angiotensin receptors (HEK293-AT1) (Figure S1A) had no major
effect on a 24-hr 3H-inositol labeling of PtdIns or its phosphory-
lated forms; in fact, their labeling was slightly increased (Fig-
ure 1B). In contrast, knockdown of Nir2 had a profound inhibitoryc.
effect on 24-hr 3H-labeling, and this equally affected PtdIns
and its phosphorylated forms, PtdIns4P and PtdIns(4,5)P2
(Figure 1B).
Since 24-hr labeling labels the inositide pools to 70% of
equilibrium (Figure S1B), these findings could be caused either
by a decrease in the size of the PtdIns pools or by a defect in
PtdIns synthesis manifested at the end of the 3-day knockdown
period. To further analyze this question, we performed experi-
ments with shorter-term 32P-phosphate labeling and agonist
stimulation. The advantage of this approach is that a shorter la-
beling period informs on the metabolic fluxes between PI cycle
intermediates rather than on their absolute levels. Cells were
labeled with 32P-phosphate for 1 hr and stimulated with angio-
tensin II (AngII) for the last 10 min in the presence of the isotope.
Phospholipid analysis showed that Nir2 downregulation
decreased the 32P-labeling response to AngII in both PtdOH
and PtdIns, but the 32P-labeling of PtdIns was more profoundly
affected (Figure 1C). While the decrease in PtdOH 32P labeling
could reflect a smaller DG response, the larger decrease in
PtdIns labeling suggested an additional block between PtdOH
formation and PtdIns synthesis. We calculated PtdOH/PtdIns ra-
tios as a more sensitive indicator of a block in the flux of 32P from
PtdOH to PtdIns. These ratios showed an increase after AngII
stimulation, which was then significantly augmented in Nir2-
knockdown cells (Figure 1D).
Nir2 Is Required for CDP-DG Synthesis during Agonist
Stimulation
The decreased [3H]-Ins labeling of PtdIns together with a
reduced [32P] flux between PtdOH and PtdIns in Nir2-depleted
cells raised the possibility that some of the PtdOH may not
have been used for PtdIns synthesis in AngII-stimulated cells.
This would occur if the transfer of PtdOH between the PM and
the ER was impaired. In this case, one would expect a defect
in CDP-DG synthesis in the ER in Nir2-depleted cells after AngII
stimulation. Therefore, we measured CDP-DG levels in cells
labeled with [3H]-cytidine and knocked down Nir2 with different
duplexes (Figure S1A). As observed earlier by other laboratories
(Stubbs and Agranoff, 1993), agonist stimulation alone did not
elicit a measurable increase in [3H]-CDP-DG levels. However,
when cells were depleted in myo-inositol overnight and treated
with 10 mM Li+ for 30 min, a procedure that blocks InsP mono-
phosphatases (Berridge et al., 1982) and deprives PtdIns synthe-
sis with one of its substrates, myo-inositol (Allison and Stewart,
1971), AngII stimulation led to a significant accumulation of
[3H]-CDP-DG (Figure 1E). This confirmed conclusions from
earlier studies that most of the CDP-DG produced as a result
of phosphoinositide breakdown is recycled back to PtdIns via
CDP-DG.
Importantly, Nir2 knockdown substantially decreased the
AngII-stimulated [3H]-CDP-DG response, suggesting a defect
in recycling the PLC-generated lipid products for CDP-DG syn-
thesis in Nir2-depleted cells. Shorter (2-hr) 3H-inositol labeling
(in this case, without inositol depletion and without Li+ treatment)
also showed that Nir2 depletion resulted in decreased [3H]-Ins
incorporation into PtdIns, consistent with a defect in CDP-DG
formation (Figure 1F). Several Nir2 small interfering RNAs
(siRNAs), some targeting the non-coding region, were tested to
rule out off target effects. These yielded similar results, and theDeveseverity of their effects appeared to be proportional to the level
of Nir2 knockdown (Figures 1C–1F and S1A).
Initial efforts to rescue the effects of Nir2 knockdown by over-
expression of RNAi-resistant Nir2 constructs were unsuccessful,
often showing even further inhibition rather than rescue in
3H-cytidine labeling experiments. This was caused by cytotox-
icity of the overexpressed Nir2 protein during prolonged expres-
sion, the reason for which is still under investigation. Careful titra-
tion of the expression levels of Nir2 using a set of plasmid with
increasing truncations within the cytomegalovirus (CMV) pro-
moter (described in Morita et al., 2012) revealed that rescue
was possible at low levels of Nir2 expression (Figure S1C).
Because of the cytotoxic effects of both the Nir2 knockdown
and prolonged Nir2 overexpression, rescue experiments were
difficult to properly dose and evaluate.
Nir2 Is Important for Sustained PLC Signaling
To determine whether Nir2 knockdown had an impact on the
ability of the cells tomaintain signaling, we tested several cellular
responses. Cytoplasmic Ca2+ measurements showed that cells
depleted in Nir2 could not maintain increased [Ca2+]i levels in
response to AngII stimulation (Figure 2A). Recent studies sug-
gested that Nir2 depletion resulted in a decrease in PtdIns(4,5)
P2 levels, which resulted in decreased signaling (Chang et al.,
2013; Kim et al., 2013a). Tomeasure the impact of Nir2 depletion
on the level of PtdIns(4,5)P2 pool, we used fluorescence reso-
nance energy transfer (FRET) measurements using the
PtdIns(4,5)P2 binding domain of Tubby (Szentpetery et al.,
2009). Lipid binding domains fused to two different fluorophores
(mTq and Venus) can serve as donor and acceptor pairs for en-
ergy transfer when they are bound to the lipid in the PM (van Der
Wal et al., 2001). Addition of ionomycin (10 mM) leads to a com-
plete breakdown of PtdIns(4,5)P2, causing the Tubby domain to
fall off the membrane and thereby decreasing the FRET signal.
The size of the FRET change in response to complete elimination
of PtdIns(4,5)P2 can inform about the size of the resting
PtdIns(4,5)P2 pool. These experiments showed only a moderate
but statistically significant reduction of the PtdIns(4,5)P2 pool in
Nir2-depleted cells (Figure 2B).
Next, we followed the DG and PtdOH responses of the cells,
applying the same FRET principle, using a DG sensor based
on the C1ab domain of PKD described previously (Kim et al.,
2011) and a PtdOH sensor based on a short sequence of the
yeast Spo20 protein (Kassas et al., 2012). The Spo20 sensor
was modified for this analysis by adding a nuclear export signal
(NES) to counter its high nuclear localization and mutating two of
the cysteines that reacted with the PLC inhibitor, U73122. These
modifications allowed the probe to be used as a faithful PtdOH
sensor (Figure S2). These results showed that the DG response
was smaller and more transient in the Nir2-depleted cells (Fig-
ure 2C). Unexpectedly, the PtdOH response was increased
rather than decreased in the cells knocked down for Nir2
(Figure 2D).
The decreased Ca2+ and DG responses were consistent with
diminishing PtdIns(4,5)P2-derived signals in Nir2-depleted cells,
as observed in recent studies (Chang et al., 2013; Kim et al.,
2013a). However, the enhanced PtdOH response of Nir2-
depleted cells suggested either an increased DG kinase activity
or a decreased PtdOH utilization at the PM. The results of thelopmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Inc. 551
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Figure 2. Nir2 Is Needed for Sustained PLC
Signaling
(A) Cytoplasmic Ca2+ responses of Fura-2-loaded cells
stimulated with AngII. Cells were treated with control
siRNA or siRNA#1 against Nir2 for 3 days before Ca2+
measurements. Means ± SEM from 60 to 70 cells.
(B–D) FRET measurements to quantify lipid changes in
live cells showing schematics of the principles. FRET
signal was measured by expressing mTq and Venus-
tagged fluorescent reporters that bind specifically to
the lipids indicated. Cells were treated with Nir2 siRNA
#1 or control siRNA for 3 days and FRET sensors were
expressed for the last day. (B) The Tubby domain was
used to assess resting levels of PtdIns(4,5)P2. The
magnitude of FRET change after a complete elimina-
tion of PtdIns(4,5)P2 by treatment with 10 mM ion-
omycin is proportional to the resting PtdIns(4,5)P2
levels. Means ± SEM, n = 77 and 66 for control andNir2
siRNA groups, respectively, obtained in three inde-
pendent knockdown experiments (p < 0.05 by un-
paired t test). (C and D) Kinetics of DG (C) and PtdOH
(D) changes after AngII (107 M) stimulation in control
and Nir2-depleted cells using FRET analysis. Means ±
SEM are shown from a total of 150–200 cells obtained
in two or three separate dishes from three independent
experiments. The translocations of wild-type and
mutated Spo20 probe are shown in Figure S2.metabolic labeling studies (Figure 1) made the latter explanation
more plausible.
Nir2 Is Enriched in ER-PM Contact Zones following PLC
Activation
Recent studies showed Nir2 in ER-PM junctions after receptor
stimulation (Chang et al., 2013; Kim et al., 2013a). We observed
a similar translocation after AngII stimulation in the HEK-AT1
cells (Figure 3A) and also in ATP-stimulated COS-7 cells or
carbachol-stimulated CHO cells (Figure S3A). Although ex-
pressed GFP-Nir2 was mostly cytosolic, association of the
protein with the ER membranous network could be observed
in cells showing low expression levels (Figures 3A and S3A).
The ER association wasmore prominent when the cytosolic frac-552 Developmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Inc.tion of the protein was released with saponin
permeabilization. This also revealed associa-
tion of Nir2 primarily with part of the ER that
followed the microtubule architecture (Fig-
ure S3B). No localization to the Golgi was
observed in live cells, even if a higher ER
density was observed around the Golgi re-
gion (Figure S3C). The punctate appearance
of Nir2 after PLC activation completely over-
lapped with that of the ER Ca2+ sensor pro-
tein, STIM1 (Liou et al., 2005) (Figure 3B).
Importantly, however, depletion of the ER
Ca2+ stores with thapsigargin, a treatment
that causes a strong STIM1 translocation
response, failed to elicit any change in Nir2
distribution (not shown). The latter was only
induced after PLC activation and was quickly
reversed after the addition of the PLC inhibi-tor, U73122 (Figure 3A). These results confirmed that Nir2 was an
ER-associated peripheral protein in the quiescent state but after
PLC activation it also formed contacts with the PM. To determine
if the punctate appearancewas due to the recruitment of the pro-
tein to specialized PM regions or was caused by its association
with the ER-bound VAP-B protein (Amarilio et al., 2005; Peretti
et al., 2008), the localization response of the FFAT mutant
(FF350,351>AA) Nir2 was studied. This mutant protein was fully
cytosolic but rapidly translocated uniformly to the PM (Figure 3C)
(these images show the middle section of cells, so the puncta
appear in the cell periphery as opposed to the whole surface
that is seenwhen the bottom of the cell was imaged). This finding
argued against the role of specialized regions in the PM as the
cause of the punctate pattern after stimulation.
AB mRFP-STIM1 GFP-Nir2
+ATP
C
merge
CDS2-GFPmCherry-Nir2 merge
control
ATP 5 min
D
E
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Figure 3. Nir2 Is ER-Associated in Resting Cells and Translocates to ER-PM Contact Sites following PLC Activation
Confocal images of live cells are shown.
(A) GFP-tagged Nir2 expressed at a low level shows faint ER localization in quiescent HEK293-AT1 cells that changes into a punctate pattern after AngII
stimulation, as best seen in the bottom section of the cells. Punctation is reversed by inhibition of PLC by U73122 (5 mM). Figure S3A shows Nir2 translocation in
other cells stimulated by other PLC activating receptors.
(B) Nir2 puncta in stimulated cells co-localize with ER-PM contact sites as marked by Stim1 proteins in COS-7 cells. Top panels show localization of the two
proteins before ATP (50 mM) stimulation and their merged image. Bottom panels show localization after ATP stimulation (5 min) and the enlarged overlay from the
area indicated by the white box. Close inspection of these areas indicates that Nir2 occupies slightly larger areas than Stim1 in the ER-PM junctions. Figure S3
shows co-localization of Nir2 with microtubules in quiescent cells after permeabilization (Figure S3B) and lack of Golgi localization (Figure S3C).
(C) GFP-Nir2 mutated in the FFAT domain is fully cytoplasmic in quiescent HEK293-AT1 cells and translocates evenly to the PM after stimulation. Note that here,
the middle sections of the cells are shown.
(D) GFP-VAP-B and mCherry-Nir2 were transfected in HEK293-AT1 cells. Two proteins were co-localized in the ER before stimulation (upper rows), and after
AngII (107 M) stimulation for 5 min, both the Nir2 and VAP-B proteins show clustering (lower rows).
(E) COS-7 cells expressingmCherry-Nir2 and CDS2-GFPwere imaged before and after stimulation with ATP (50 mM) for 5min. Note the localization of Nir2 puncta
at ER regions that also show some enrichment in CDS2, although these are not as prominent as with VAP-B. Bars are 10 mm. See Figures S3D and S3E for TIRF
analysis of co-localization of Nir2 and CDS2 and the confocal analysis of the Nir2 and PIS proteins, respectively.To determine whether VAP-B expression increases the ER-
associated fraction of Nir2 and whether VAP-B also redistrib-
utes during Nir2 translocation, we co-expressed mCherry-
tagged Nir2 and a GFP-VAP-B construct in HEK293-AT1 cells
and observed the distribution of both proteins before and
after AngII stimulation. As shown in Figure 3D, VAP-B ex-
pression increased the ER association of Nir2 and after stim-
ulation both protein showed clustering and co-localization in
the junctional compartment. It was also of interest that Nir2
and CDP-DG synthase (CDS) showed co-localization during
agonist stimulation (Figure 3E). This co-localization in the con-Devetact zones was even more prominent in total internal reflection
fluorescent microscopy (TIRF) images (Figure S3D); here, Nir2
was not detected at the membrane in quiescent cells, but
after stimulation, it rapidly moved to PM-adjacent puncta,
where it showed close co-localization with the CDS2 protein.
It was difficult to determine whether the CDS2 protein
showed further enrichment in the same compartment in
response to stimulation. Notably, Nir2 showed no co-localiza-
tion with the rapidly moving particles of PI synthase (PIS)
enzyme only with the fraction that was present in the tubular
ER (Figure S3E).lopmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Inc. 553
Nir2 Facilitates the Clearance of PtdOH from the PM
All of the data above, together with the localization of Nir2 in the
ER-PM contact zones, raised the question as to whether Nir2 fa-
cilitates the transfer of PtdOH between the PM and the ER. To
test whether Nir2 affects the clearance of PtdOH from the PM,
we stimulated cells with AngII for 10 min to allow the accumula-
tion of PtdOH. At this point, we added a DG kinase inhibitor
(50 mM R59022) to block further PtdOH production and exam-
ined the rate at which PtdOH is removed from the PM. Because
of the light-induced inactivation of the inhibitor at 430 nm illumi-
nation, we used a red version of the PtdOH sensor (NES-
mdsRed-Spo20) and measured its cytosolic intensity changes
in confocal microscopy to follow its membrane association (the
568 laser line had a less damaging effect on the inhibitor). AngII
stimulation rapidly increased DG at the PM, which was reflected
in the recruitment of the DG probe to the PM with concomitant
decrease in the cytosolic fluorescence (note that the decrease
in cytosolic intensity is plotted upward to reflect the direction
of lipid changes in the membrane). It took a few minutes before
the PtdOH probe translocated to the PM, and its increase coin-
cided with the dropping DG levels. Inhibition of DG kinases
caused an immediate increase in PM DG levels and initiated a
decline in PtdOH levels (Figure 4A). To study the effect of Nir2
on the disappearance of PtdOH from the PM, we expressed
GFP-Nir2 and used this treatment protocol comparing the
Spo20 probe translocation kinetics between cells expressing
GFP-Nir2 and those expressing only the empty plasmid (Fig-
ure 4B). Remarkably, in cells expressing GFP-Nir2, the accumu-
lation of PtdOH after AngII stimulation was reduced and more
importantly, PtdOH disappeared from the PM faster and more
completely after addition of the DG kinase inhibitor (Figure 4B).
We next examined whether this effect was related to the PITP
domain and performed similar experiments with mutant GFP-
Nir2 proteins. Mutant Nir2 lacking the PITP domain was unable
to facilitate PtdOH clearance (Figure 4C, top), and mutation of
the FFAT domain (FF350,351>AA), which eliminates interaction
with the ER-bound VAP-B protein, greatly reduced but did not
completely eliminate the effect (Figure 4C, top). Point mutations
at the T59 residue (T59A or T59E) within the Nir2 PITP domain
that had previously been shown to affect PtdIns transfer
in vitro (Milligan et al., 1997) also prevented the stimulatory effect
on PtdOH clearance (Figure 4C, middle). Conversely, the iso-
lated PITP domain of Nir2 was partially active (comparable to
the FFAT mutant), while RdgBb was without effect (Figure 4C,
bottom). These results together suggested that Nir2 is able to
facilitate the clearance of PtdOH from the PM and the next
step was to assess where this PtdOH was utilized.
Importantly, PtdOH was not detected in the ER with the
Spo20-based PtdOH sensor, even when the clearance of PtdOH
from the PMwas enhanced by Nir2. This most likely reflected the
rapid utilization of PtdOH in the ER by the CDS enzymes. To test
this possibility, we performed 32P-phosphate labeling experi-
ments in cells expressing Nir2. Moderate overexpression of
Nir2 (an untagged version was used in these studies), but not
its PITP-domain-deleted mutant, showed an increased
32P-phosphate labeling of PtdIns after a 10-min AngII treatment
(Figure 5A). Importantly, this was paralleled by a decreased
32P-phosphate labeling of PtdOH (Figure 5A). The increased
conversion of PtdOH to PtdIns was most apparent as a signifi-554 Developmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Incant decrease in the 32P-labeled PtdOH/PtdIns ratios in AngII-
stimulated cells expressing Nir2, but not its PITP-less version
(Figure 5B). In further experiments using CDP-DG labeling, mod-
erate Nir2 overexpression also increased the amount of CDP-DG
formed, and this effect was not reproduced by the PITP-domain-
deleted Nir2 (Figure 5C). These results together were consistent
with an enhanced PtdOH to PtdIns conversion by Nir2 as a
consequence of enhanced transfer of PtdOH from the PM to
the ER.
Mechanism of the PM Association of Nir2
Nir2 has multiple domains that show homology to those found in
various protein families (Figure S4A). Notable among these are
the N-terminal PITP domain and an LNS2 domain toward the C
terminus also found in lipins (Kim et al., 2013a). Nir2 also has a
DDHD domain found in a family of proteins comprising PLA1/
DDHD1, p125/Sec23-interacting protein, and KIAA0725p/
DDHD2 (Inoue et al., 2012). This latter domain has been claimed
to bind PtdIns4P (Inoue et al., 2012).We also noted that the LNS2
domain is preceded by a short sequence that is not homologous
in lipins but is present in a group of bacterial and archaeal pro-
teins called ‘‘PITPs’’ that also have LNS2 domains but lack
PITP domains (Figure S4A). This small segment showed vague
similarity to the DG binding part of C1 domains. We designated
this conserved segment as DGBL (for DG-binding-like) (Figures
S4A and S4B).
Although the FFAT-mediated association of Nir2 with the VAP
proteins in the ER has been established (see above and Amarilio
et al., 2005), the mechanism of PM association of the protein is
less understood. Recent studies showed that Nir2 binds to
PtdOH via its LNS2 domain (Kim et al., 2013a). However, analysis
of the kinetics of Nir2 PM association after stimulation showed
that it was significantly faster than the recruitment of the PtdOH
sensor, Spo20, yet it was still slower than the DG increase (Fig-
ure 6A). Remarkably, a PITP-deleted construct showed a PM-
association response that was significantly faster and greatly
enhanced compared to Nir2 wild-type (Figure 6B), indicating
that the PITP domain was not responsible for PM association
and exerted a negative, possibly regulatory effect on membrane
interaction.
Serial truncations from the N and C termini were then gener-
ated (Figure 6C), and the PM translocation responses of these
fragments were analyzed after AngII stimulation followed by
DGK inhibition (Figure 6D). A small deletion from the C terminus
(1182stop) had no effect on the localization response. However,
a larger deletion (1118stop) completely eliminated membrane
recruitment. Deletion of the entire N terminus up to residue 966
also eliminated membrane recruitment. These experiments
showed that the narrowly defined LNS2 domain was necessary,
but not sufficient, for membrane recruitment. Addition of the
DGBL segment to the LNS2 domain (residues 816–1181)
restored the PM localization response, which was further
enhanced by extension of the construct toward the N terminus
(420–1181) (Figure 6C). Importantly, the PM association of these
constructs was not reversed after DGK inhibition (Figure 6D).
The fast membrane-association kinetics and the lack of its
reversal by DG kinase inhibitors suggested that PtdOH might
not be the sole lipid responsible for the membrane association
of Nir2. The requirement for the DGBL segment and the fastc.
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Figure 4. Nir2 Expression Facilitates Removal of PtdOH from the PM
(A) Kinetics of DG (black) and PtdOH (red) changes after AngII (107 M) stimulation in HEK293-AT1 cells expressing GFP- and mdsRed-fused DG and PtdOH
sensors, respectively (see Experimental Procedures for details). Transfected cells were imaged live by confocal microscopy, and the cytoplasmic intensity was
monitored in the cytosol in regions of interest outside the nuclear area. Translocation to the PM is associated with a decrease in cytoplasmic fluorescence.
Decreased intensities are plotted upward for easier conceptualization of the direction of changes in membrane lipid concentrations. AngII (107 M) and the DG
kinase inhibitor, R59022 (50 mM), were added at the indicated times. The detailed time course is shown as means ± SEM of 11–12 cells obtained in one
representative experiment reproduced three times.
(B) Expression of GFP-Nir2 facilitates the removal of PtdOH from the PM. Representative pictures show a group of cells after AngII stimulation followed by DG
kinase inhibition at times indicated by the dotted lines. Note that cells that do not express GFP-Nir2 (white arrows) still show PM localization of the PtdOH sensor,
while the localization is completely eliminated in those expressing the GFP-Nir2 protein. Scale bar, 10 mm.
(C) Quantification of cytoplasmic fluorescence changes in similar experiments using various mutant Nir2 constructs or the RdgBb protein. Means ± SEM from 20
to 40 cells obtained in three separate experiments are shown.localization response raised the possible role of DG as another
lipid binding factor in addition to PtdOH. This was tested by us-
ing DiC8-DG added to the cells expressing the GFP-Nir2(420–Deve1181) or GFP-Nir2(816–1181) constructs. This treatment caused
rapid translocation of both the DG sensor (Kim et al., 2011) and
the Nir2 construct (Figure 6E) to the membrane, even afterlopmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Inc. 555
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Figure 5. Effects of Nir2 Overexpression on
PtdOH Labeling and CDP-DG Production
(A) 32P-labeling with or without AngII (107 M)
stimulation in HEK293-AT1 cells transfected with
empty vector, Nir2, or DPITP-Nir2 for 1 day.
Representative image of a TLC analysis and re-
sults of quantification of PtdOH (upper) and PtdIns
(lower) from three experiments performed in
duplicate (grand mean ± SEM).
(B) Calculated PtdOH/PtdIns ratios (normalized to
absolute controls) were significantly decreased in
cells expressing Nir2 compared to those trans-
fected with vector or DPITP-Nir2 (grand mean ±
SEM, n = 5 duplicates, **p < 0.01; ***p < 0.001
using two-way ANOVA).
(C) [3H]cytidine incorporation into CDP-DG in
HEK293-AT1 cells transfected with empty vector,
Nir2, or DPITP-Nir2. Values were normalized to
those obtained with AngII-stimulated Nir2-ex-
pressing cells (grand mean ± SEM, n = 8 dupli-
cates; ***p < 0.005, using two-way ANOVA).inhibition of DGK (Figure S4F). However, truncations of this
construct from the C terminus (420–1117) or (420–978)
completely prevented its membrane recruitment response to
AngII stimulation. Mutation of the V934A/L935A residues within
the DGBL domain in the GFP-Nir2(420–1181) construct reduced,
but did not eliminate, the response to DiC8-DG, and also reduced
the response to AngII stimulation (Figure 6G).
To further analyze the role of the PITP domain and the DG-
binding-like segment in the full-length Nir2 protein, we generated
point mutations within these respective domains (T59A and T59E
and V934A/L935A, respectively). The T59 mutants showed
stronger membrane association with similar kinetics to the
wild-type Nir2, while the VL>AA mutant showed a very muted
membrane translocation response (Figure 6F). These results
together suggested that the PM interaction is a more complex
process mediated by a combined action of DG and PtdOH bind-
ing by the C-terminal segment, requiring both the LNS2 and the
DGBL segment. Importantly, this process was negatively
controlled by the PITP domain.
DISCUSSION
The present experiments were initiated to address the question
of which, if any, of the PITP proteins contribute to the transfer
of PtdIns between the ER and the PM. Mammalian PITP proteins
have been thoroughly studied and well characterized mostly us-
ing in vitro systems, but it has been an unresolved question
whether they, indeed, are the proteins responsible for the trans-
fer of PtdIns between the ER and PM (Cockcroft and Garner,
2011; Ile et al., 2006). Our attention was drawn to the Nir2 protein
because it was the only one that had profound effects on the la-
beling of phosphoinositides. Our studies revealed that the Nir2
protein functions in ER-PM contact zones and responds to stim-
ulation with PLC-activating stimuli by translocation to these junc-
tional sites. While our experiments approached their conclu-556 Developmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Insions, three studies reported important findings on this topic.
The paper by the Cockcroft group has reported that RdgBb
(a protein that has high homology to Nir2 PITP domain but lacks
the other parts of the Nir2 molecule) is capable of PtdOH binding
in vitro (Garner et al., 2012). Two recent studies from the Lev and
Liu groups showed that Nir2 translocated to the PM in stimulated
cells and that the Nir2 protein was important for themaintenance
of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 pools in the PM, presumably
due to the protein’s PtdIns transfer function (Chang et al., 2013;
Kim et al., 2013a).
Our studies are in good agreement with those findings. How-
ever, they also revealed an additional feature of Nir2; namely,
its ability to function as a PtdOH transfer protein that operates
within ER-PM contact zones. Our studies showed that Nir2-
depleted cells accumulate PtdOH in their PM and are impaired
in converting PtdOH to CDP-DG and PtdIns during PLC activa-
tion. The moderate decrease in PtdIns(4,5)P2 levels in Nir2-
depleted but unstimulated cells suggest that cells can maintain
this important PM lipid even when PtdIns transfer is impaired
and PtdIns pools are shrinking in the ER. Our structural analysis
of themembrane association of Nir2 in activated cells suggested
a more complex recruitment process than previously described
(Kim et al., 2013a). The inhibitory effect of the PITP domain on
membrane localization indicates that lipid binding to the PITP
domain is probably an important clue for themolecule to assume
a more open conformation that allows the other domains to bind
both the ER and the PM. None of our deletion constructs fol-
lowed either DG or PtdOH kinetics; rather, their PM association
kinetics suggested that both DG and PtdOH binding was impor-
tant for the membrane localization of the C-terminal segments of
the protein. Whether these two lipids bind to the same or
different sites remains to be established. It is important to note
that all of our conclusions were reached based on experiments
in intact living cells using an array of methods from biochemical
analysis to dynamic confocal imaging.c.
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Figure 6. Kinetic Analysis of the Membrane Association of Nir2 Constructs Relative to DG and PtdOH Changes
HEK293-AT1 cells were co-transfected with the indicated constructs for one day and observed in confocal microscopy. Cytoplasmic fluorescence changes were
recorder in regions of interest outside the nuclear area and expressed as percent of pre-stimulatory values. Translocation to the PM is associated with a decrease
in cytoplasmic fluorescence. Decreased intensities are plotted upward for easier conceptualization of the direction of changes in membrane lipid concentrations.
(A) Translocation of GFP-Nir2 is faster than the PtdOH increase (measured by Spo20m) but slower than that of DG (measured by the GFP-C1ab domain of PKD;
Kim et al., 2011). Means ± SEM from 19 to 33 cells obtained in three independent experiments.
(B) Removal of PITP greatly enhances the speed and extent of membrane association (means ± SEM of six to eight cells from a representative experiment
reproduced four times). Both the basal ER association and the AngII-induced punctuation of this construct are enhanced relative to full-length Nir2 (lower panels).
(C) Schematic representation of the Nir2 constructs tested in this study for their membrane association in response to AngII or DiC8-DG. Black lines represent
constructs with no membrane recruitment, and red and orange colors mean good and intermediate recruitments, respectively. Figure S4 shows homology of the
various domains of Nir2 with other proteins and the sequence alignment of the DG-binding-like domain (DGBL) with C1 domains and bacterial ‘‘PITP’’ proteins.
(D) Rapid membrane association of the Nir2(420–1181) and Nir2(816–1181) constructs after AngII stimulation alone (brown and cyan traces) or followed by DGK
inhibition (red and blue traces). Means ± SEM from eight to nine cells obtained in one representative experiment reproduced two times.
(E and G) Membrane association of the Nir2(420–1181) construct and its mutant (V934,L935>AA) after DiC8-DG (30 mM) (E) or AngII (G) treatment. Means ± SEM
from n = 36–94 cells obtained in three to five dishes from three independent experiments.
(F) Membrane association of the indicated full-length Nir2 constructs after AngII treatment followed by DGK inhibition. Means ± SEM from 19 to 34 cells obtained
in four to six dishes from three independent experiments. See Figure S4 for localization of and translocation of Nir2(420–1181) and Nir2-VL>AA mutants.These findings fill an important gap in our understanding of the
so-called PI cycle, whereby the products of the PLC-mediated
breakdown of PtdIns(4,5)P2 in the PM are recycled back intoDevethe ER. Functioning as a PtdOH transfer protein, Nir2 plays a
pivotal role in localizing the agonist-induced facilitation of the
PI-cycle to ER-PM contact zones establishing a remarkablelopmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Inc. 557
organization. Since the transfer of PtdOH is ‘‘upstream’’ of the
PtdIns transfer process in the PI cycle when accelerated by
PLC activation, it is not possible to draw a conclusion about
the role of Nir2 as a PtdIns transfer protein in the current study
(and in the other aforementioned studies). However, generation
of PtdOH by PLD2 in the PM failed to support CDP-DG produc-
tion even though it did cause recruitment of the Nir2 protein to
the contact zones (Y.K. et al., unpublished data). Only after
PLC activation was the PtdOH delivered to the CDS enzyme(s).
This strongly suggested that the PtdOH transfer was a feature
that required some form of priming and was likely coupled to
PtdIns transfer. The well-documented ability of the Nir2 PITP
domain to transfer PtdIns (Garner et al., 2012) in vitro served
as the basis of the accepted view that Nir2 transfers PtdIns
from the ER to the PM, and nothing in our findings counters those
conclusions. Taking all these data together, we propose that the
Nir2 protein works essentially as a PtdOH-PtdIns exchanger at
the ER-PM contact zones. These findings also explain several
previous puzzling results describing elements of the whole PI
cycle associated with both the PM (McPhee et al., 1991; Vaziri
et al., 1993) and the ER (Helms et al., 1991) in cell fractionation
studies. The ER-PM compartment could have been recovered
in either the ER- or PM-enriched fractions in those studies.
The Drosophila RdgB protein, the fly ortholog of Nir2, is
responsible for the inability of these mutant flies to terminate
light-induced electrical signal in electroretinograms and for the
light-induced retinal degeneration (Vihtelic et al., 1991). The
presence of a PITP domain that is highly homologous to the class
I PITPs, PITPa, and PITPb (Vihtelic et al., 1993), together with the
importance of the phosphoinositide cycle in invertebrate photo-
signal transduction, led to the assumption that RdgB functions
as a PtdIns transfer protein. This was corroborated by the find-
ings that the PITP domain of RdgB was necessary and sufficient
to rescue the mutant phenotype (Milligan et al., 1997). However,
several observations suggested that there was more to RdgB
function than a simple PtdIns transfer. First, class I mammalian
PITPa or a chimeric RdgB having the mammalian PITPawas un-
able to rescue the phenotype (Milligan et al., 1997). Second,
RdgB proteins mutated within the PITP domain (T59E) showed
a dominant-negative effect in spite of the ability of this particular
mutant to transfer PtdIns (Milligan et al., 1997). Third, the prob-
lem with signal termination was inconsistent with a simple
rundown of the PtdIns(4,5)P2 pools that was expected if the pro-
tein simply worked as a PtdIns transfer protein (Trivedi and Pa-
dinjat, 2007). Our results provide a possible explanation for all
of these findings. Defective PtdOH removal from the PM could
explain the signal termination defect. The PtdOH transfer func-
tion being upstream of the presumed PtdIns transfer function
also explains the lack of correlation with simple PtdIns transfer.
Nevertheless, it is most likely that the protein works in a dual ca-
pacity, transferring both PtdOH and PtdIns between the ER and
PM. The localization of the RdgB protein in the fly retina in the
subplasmalemmal portion of the ER called sub-rhabdomeric
cisternae (Suzuki and Hirosawa, 1994; Vihtelic et al., 1993) is
also in good agreement with the presence of the Nir2 protein in
the ER-PM junctions in stimulated mammalian cells.
It has been suggested that lipid transfer proteins may not sim-
ply function as diffusible vehicles mediating lipid transfer be-
tween membranes in a way that happens in simple lipid transfer558 Developmental Cell 33, 549–561, June 8, 2015 ª2015 Elsevier Inassays (Mousley et al., 2012). It was proposed that PITPs func-
tion as devices that assign PI lipids to various enzymatic reac-
tions in a strictly regulated biological context. Our results are fully
compatible with these views. Although we propose that Nir2 al-
lows transfer of lipids between two adjacent membranes, it does
so only in a specific biological context. Nir2 supplies PtdIns to
the PM, but only when PtdIns(4,5)P2 is consumed by PLC en-
zymes producing both DG and PtdOH, and all this happens in
restricted membrane domains formed by contacts between
the ER and the PM. While our present studies and those con-
ducted in flies suggest that a diffusible PITP domain of Nir2/
RdgB is capable of restoring the lipid transfer function, the pre-
cise and metabolically isolated function of these proteins re-
quires their localization to the contact sites.
It is also important to emphasize that Nir2 is unlikely to be the
sole protein responsible for either PtdOH or PtdIns transfer or
metabolic channeling. Other PtdIns and PtdOH transfer domains
have been identified in eukaryotic cells, such as the classical
PITPs, Nir3, RdgBb, PRELI, and Sec14 domain-containing pro-
teins (Bankaitis et al., 2010; Lev, 2012). Nir3-knockout mice
have been generated but showed no obvious phenotype (Lu
et al., 2001), and Nir3 knockdown in our hands did not produce
the same effects observed with Nir2 depletion (Y.K. and T.B.,
unpublished data). Also, RdgBb failed to enhance PtdOH clear-
ance from the PM in the present study. Although it is quite likely
that other proteins will be identified that contribute to the transfer
andmetabolic flux of these important lipids, Nir2 appears to be a
key molecule when it comes to control the flux and recycling of
these lipids during agonist-induced PLC activation.
In summary, the present study uncovers a unique feature of
the Nir2 protein; namely, its function as a PtdOH transfer device.
The agonist-induced localization of Nir2 to ER-PM junctions,
together with its role in feeding the ER-localized CDS enzyme
with PtdOH, establishes Nir2 as a central organizer of the phos-
phoinositide cycle in this unique functional compartment. The
exchange function of Nir2 is a perfect design to match PtdIns
synthesis and transfer with PtdIns(4,5)P2 utilization so that cells
can maintain the level of PtdIns(4,5)P2 during prolonged PLC
activation. These results can also explain the functional and
metabolic isolation of the agonist-controlled PtdIns cycle from
the rest of the ER-associated lipid metabolic pool.
EXPERIMENTAL PROCEDURES
Materials
Angiotensin II (human octapeptide) DG kinase inhibitor I (R59022) were from
Bachem and EMD Millipore, respectively. Saponin and U73122 were from
Sigma-Aldrich. All other chemicals were of the highest analytical grade. Anti-
bodies against PITPa and PITPb were generous gifts from Dr. Shamshad
Cockcroft (University College London). The Nir2 antibody was raised against
the peptide CRSRGPSQAEREGPG in rabbits and affinity purified (New
England Peptide). Nir2 antibodies were also generously provided by
Dr. Tiansen Li (National Eye Institute, NIH).
DNA Constructs
The human Nir2 (accession number BC022230, obtained as a full-length clone
[4396491] from Open Biosystems) was fused to pEGFP-C1 using PCR ampli-
fication with the primer pairs listed in Supplemental Experimental Procedures.
All point mutations for GFP-Nir2 were generated by the QuikChangemutagen-
esis kit (Agilent Technologies) (primers listed in Supplemental Experimental
Procedures). For rescue experiments, GFP-Nir2 or Nir2 was subcloned toc.
pcDNA3.1 vectors with CMV promoters of different strengths kindly provided
by Dr. Wes Sundquist (Department of Biochemistry, University of Utah) (Morita
et al., 2012). For this, GFP-Nir2 was amplified with different primer pairs (see
Supplemental Experimental Procedures) and digested using SpeI and SalI.
The digested fragment was then ligated to individual pcDNA3.1 vectors cut
by XbaI and XhoI. The yeast Spo20 PtdOH-binding domain (Spo2051–90) pro-
vided in a monomeric dsRed vector was a generous gift from Dr. Nicolas Vitale
(University of Strasbourg). An NES (ALQKKLEELELDE from MAPKK) was
added to the N terminus of dsRed, but this construct was not fully excluded
from the nucleus. Therefore, there were two more versions of the construct
created (one having two NES signals at the N terminus, the other having one
NES signal at the N terminus and another between dsRed and the Spo20
sequence). Both of these constructs were equally excluded from the nuclei
and behaved similarly as PtdOH sensors. In subsequent experiments using
U73122, we found that the sensor was recruited to the PM by this reagent.
To generate a version without this undesirable feature, we mutated both
cysteine residues (Cys54 and Cys82) to serine. This made the probe compat-
ible with the PLC inhibitor, U73122. For FRET measurements of DG, the previ-
ously described DG sensor (NES-GFP-PKDC1ab [W166A]; (Kim et al., 2011)
was generated using mTq2 (a kind gift from Dr. Theodorus Gadella, University
of Amsterdam) and Venus in place of GFP. For PtdOH FRET studies, the dou-
ble-cysteine mutant Spo20-based sensor was used with an additional NES
signal (ALQKKLEELELDEQ) placed between the fluorophore (mTq or Venus)
and the Cys mutated Spo20 peptide. The GFP-tagged Tubby domain was
described previously (Szentpetery et al., 2009). GFP-VAP-B and HA-PLD2
were generous gifts from Dr. Chris Stephan (Cornell University) and Dr. John
H. Brumell (Cell Biology Program, Hospital for Sick Children), respectively.
RNAi
The target sequences for various Nir2 siRNA were as follows. #1: 50-
AAGGTCTCTGGCTTCTTCCTC-30, #2: 50-CCAGTGTGTATAAATCCATGA-30,
#3: 50-CGGCTTTATCACTCGGTCA-30, #4: 50-TGAGAACAGCTCCGAGGAA-30,
and #5: 50-CAGCCTGGACCTGGGTTATTT-30. The target sequences of PITPa
and PITPb were 50-AAGGATGGAAGAAGAGACGAA-30 and 50-CGGGAAGAT
GGTGCTGATCAA-30, respectively. Oligonucleotide duplexes were obtained
from QIAGEN.
Transfection of Cells for Microscopy or RNAi
COS-7 cells or HEK293-AT1 cells (a HEK293 cell line stably expressing the rat
AT1a angiotensin receptor) were plated onto 25-mm-diameter poly-L-Lysine-
coated circular glass coverslips in six-well plates (300,000 cells/well), and
plasmid DNAs (0.5-1 mg/well) were transfected using the Lipofectamine2000
reagent (Invitrogen) and OPTI-MEM (Invitrogen) following the manufacturer’s
instructions. The target sequences for various Nir2 siRNAs are described
above. Cells were cultured in either six-well dishes (for microscopy) or 12-
well plates (for metabolic labeling studies) and treated with 100 nM siRNA
using the RNAiMAX reagent (Invitrogen), and they were analyzed after
3 days treatment with the siRNA. For the rescue experiment, 1 day after siRNA
treatment, HEK293-AT1 cells were transfected with 0.5 mg of various CMV-
promoter-driven Nir2 constructs for 2 days.
Live-Cell Imaging
After 20–24 hr of transfection, cells were washed on the glass coverslips with a
modified Krebs-Ringer solution (containing 120mMNaCl, 4.7mMKCl, 1.2mM
CaCl2, 0.7 mM MgSO4, 10 mM glucose, and 10 mM Na-HEPES [pH 7.4]), and
the coverslip was placed into a metal chamber (Atto, Invitrogen). Cells were
examined in inverted microscopes in 1 ml of the Krebs-Ringer buffer. Stimuli
were dissolved and added in 200 ml buffer removed from the cells. Confocal
images were obtained with a Zeiss LSM 510 or LSM 780 laser confocal micro-
scope (Carl Zeiss MicroImaging) using a 633 1.4-numerical-aperture plan-
apochromatic objective. TIRF analysis was performed in an Olympus dual
launch TIRF microscope system equipped with a Photometrics Cascade II
camera and a PlanApo 603/1.45 objective.
FRET Measurements
HEK293-AT1 cells grown on poly-Lysine-coated glass coverslips were co-
transfected with themTq- and Venus-tagged versions of theDG or PtdOH sen-
sors (0.4 mg DNA each) for 24 hr. Coverslips were mounted into Atto chambersDeveand examined in an Olympus IX70 inverted microscope equipped with a
Lambda DG4 illuminator (Sutter Instruments) and a beam splitter appropriate
for CFP-YFP separation (Photometrics) and a MicroMax BFT camera (Photo-
metrics). Data acquisition and processing was done with the Metafluor soft-
ware of Molecular Devices. Data are presented as 530/475 emission ratios
normalized to initial values in each cells. Several cells per dish were analyzed
frommultiple dishes per experiments, which were repeated three independent
times with separate knockdown.
Measurements of Receptor-Stimulated DG or PtdOH Kinetics using
DG or PtdOH Sensor
HEK293-AT1 cells were transfected with the NES-GFP-PKDC1ab (W166A) or
NES-dsRed-NES-Spo20m construct. After 24 hr, cells were imaged in a Zeiss
LSM 780 confocal microscope at room temperature. After stimulation with
100 nM AngII, translocation of the fluorescent probe was monitored in time-
lapse imaging. The translocation of the construct from the membrane to the
cytosol was quantified by measuring cytosolic fluorescent intensity in regions
of interest outside the nucleus and plotted against time using the Zeiss image-
processing software. Intensity curves were normalized to pre-stimulatory
values, and they were averaged from the indicated number of cells in record-
ings obtained in several dishes in multiple independent experiments.
Analysis ofmyo-[3H]Inositol-, [32P]Phosphate-,
or [3H]cytidine-Labeled Lipids
HEK293-AT1 cells plated on 12-well plates were labeled withmyo-[3H]inositol
(20 mCi/ml) in inositol-free DMEM supplemented with 2% dialyzed fetal bovine
serum for 2 or 24 hr. When added, AngII (107 M) was present for the entire
short-term labeling period. For 32P-phosphate experiments, 2 mCi/ml o-[32P]
phosphate was used for 1-hr labeling in phosphate-free DMEM and AngII
was added for 10 min. For [3H]cytidine labeling, cells were incubated in
inositol-free medium overnight and labeled with 10 mCi/ml [3H]cytidine in a
modified Krebs-Ringer solution for a total of 90 min. Li+ (10 mM) was added
at 30 min and AngII at 60 min. In some cases, longer incubation with AngII
(60 min) was used with accordingly extended labeling. The labeling was termi-
nated by the addition of ice-cold perchloric acid (5% final concentration), and
cells were kept on ice for 30min. After scraping and freeze-thawing, cells were
centrifuged and the cell pellet was processed to extract the lipids by an acidic
chloroform/methanol extraction followed by thin layer chromatography (TLC)
essentially as described previously (Nakanishi et al., 1995). For some experi-
ments using [3H]cytidine labeling, TLCwas not performed but the entire extract
was evaporated and analyzed by scintillation counting, since a negligible
amount of radioactivity was associated with lipids other than CDP-DG.
32P-labeled samples were analyzed with phosphoimager, while [3H]-labeled
samples were sprayed with autoradiography Enhancer (PerkinElmer) and
exposed to X-ray films with multiple exposures. In some cases, 3H-labeled
lipids were also scraped and counted in scintillation counters for comparison.
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